Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii : A Prospective, Observational Study
ConclusionsThis real-life clinical experience concerning the therapeutic approach to severe pneumonia caused by MDR-AB provides useful suggestions to clinicians, showing the use of different antibiotic regimens with a predominant role for fosfomycin. Further randomized clinical trials are necessary to confirm or exclude these observations.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Acinetobacter | Clinical Trials | Infectious Diseases | Multidrug Resistance | Pneumonia | Septic Shock | Study